• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.09% Nasdaq Up 0.30%

    Alkermes plc (ALKS)

    -NasdaqGS
    48.13 Down 3.65(7.05%) 4:00PM EDT
    Prev Close:51.78
    Open:51.07
    Bid:47.47 x 500
    Ask:65.10 x 100
    1y Target Est:49.00
    Beta:2.03059
    Next Earnings Date:28-Jul-16ALKS Earnings announcement
    Day's Range:47.23 - 51.50
    52wk Range:27.14 - 80.71
    Volume:1,712,971
    Avg Vol (3m):976,156
    Market Cap:7.28B
    P/E (ttm):N/A
    EPS (ttm):-1.83
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALKSDown 7.05%7.28B
    LLYDown 0.56%87.51B
    GSKUp 0.13%109.74B
    ABTUp 1.79%65.30B

    Key Statistics

    Forward P/E (1 yr):253.32
    P/S (ttm):12.55
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.26
    Quarterly EPS Est (Jun-16) :-0.10
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):7.01

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products that are designed to address unmet medical needs of patients in various therapeutic areas worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback